Atwood & Palmer’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25
Closed -$1K 395
2022
Q3
$1K Hold
25
﹤0.01% 367
2022
Q2
$1K Hold
25
﹤0.01% 389
2022
Q1
$2K Hold
25
﹤0.01% 430
2021
Q4
$2K Hold
25
﹤0.01% 442
2021
Q3
$3K Hold
25
﹤0.01% 409
2021
Q2
$4K Hold
25
﹤0.01% 381
2021
Q1
$5K Hold
25
﹤0.01% 386
2020
Q4
$5K Hold
25
﹤0.01% 343
2020
Q3
$5K Buy
+25
New +$5.29K ﹤0.01% 293

Other funds holding TDOC

Atwood & Palmer's TDOC Position: Q4 2022 in Review

Atwood & Palmer sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 25 shares — an estimated $1K sold.

Atwood & Palmer first reported a position in TDOC in Q3 2020 and held it in 9 quarters. The position peaked at $5K in Q1 2021. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Atwood & Palmer reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Atwood & Palmer sold 25 Teladoc Health shares in Q4 2022, an estimated $1K.
  • Atwood & Palmer first reported a position in Teladoc Health in Q3 2020 and held it in 9 quarters.
  • Atwood & Palmer's Teladoc Health position peaked at $5K in Q1 2021.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Atwood & Palmer's 13F filing for Q4 2022, filed 31 Jan 2023.